Resources Archive - Page 36 of 51

Clinical Biomarkers

Multidisciplinary testing platforms that enable support to detect, develop, and validate biomarkers of cancer. End-to-end services in pathology, flow cytometry,...

Research Chemistry Services

WuXi AppTec’s Research Chemistry Services (RCS) is a global leading chemistry platform offering synthetic and medicinal chemistry solutions to pharmaceutical...

Rare Genetic Disease Platform

Oncology & Immunology Services From the generation and characterization of genetically engineered animal models (GEAMs) to colony management and pre-clinical...

Immunology Assays

A comprehensive in vitro platform to accelerate cancer immunotherapy drug discovery: Binding & blocking assessment (via biophysical and biochemical assays,...

Inflammatory Bowel Disease Models

We offer an extensive panel of inflammatory bowel disease models in mice and rats, including genetically modified, chemically induced, and...

Regenerable Surface Plasmon Resonance (SPR) Surfaces for Reliable, Cost-Effective, and Wide-Ranging Applications

Traditional SPR-based drug discovery efforts in the small-molecule space have revolved around single-use chips for screening and hit-to-lead efforts. Inspired...

DNA-Encoded Macrocyclic Peptide Libraries Enable the Discovery of a Neutral MDM2–p53 Inhibitor

Macrocyclic peptides are an emerging molecular class for targeting intracellular protein–protein interactions (PPIs) and for providing an oral modality for...

Discovery of RNA Targeting Small Molecules – Our Toolbox for RNA Drug Discovery

Drug Discovery Chemistry Conference 2023 WuXi AppTec has developed technologies to facilitate RNA small molecule screening, an exciting frontier in...

Biophysical and Structural Biology Methods Enable Fragment-based Covalent Ligand Discovery of Human BTK

Drug Discovery Chemistry Conference Powerful biophysical and structural biology tools enable the study of large numbers of covalent fragments and...

Knowledge Library